ALIGOS THERAPEUTICS INC (ALGS) Stock News

NASDAQ:ALGS - Nasdaq - US01626L2043 - Common Stock - Currency: USD

8.04 +0.13 (+1.64%)

After market: 8.25 +0.21 (+2.61%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ALGS Latest News, Press Relases and Analysis

All

Press Releases

7 hours ago - By: Zacks Investment Research - Mentions: RGNX

Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates

9 hours ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

9 hours ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

21 hours ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

7 days ago - By: Aligos Therapeutics

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

7 days ago - By: Aligos Therapeutics

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

3 months ago - By: Benzinga - Mentions: ENLT SSL ATKR GPOR ...

Earnings Scheduled For May 6, 2025

a month ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Presents Positive Data at the EASL Congress 2025

3 months ago - By: Zacks Investment Research - Mentions: IFRX

Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

3 months ago - By: Yahoo Finance - Mentions: UPS CAT JPM RJF ...

UPS downgraded, ServiceNow upgraded: Wall Street's top analyst calls

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025

4 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

4 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

4 months ago - By: Aligos Therapeutics

Aligos Therapeutics Presents Positive Data at APASL 2025

4 months ago - By: Aligos Therapeutics

Aligos Therapeutics Presents Positive Data at APASL 2025

5 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

5 months ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results